Titus Health Care has in 2012 to the introduction of the drug Esmya for manufacturer Gedeon Richter worked. Besides an analysis of the Dutch situation, Titus Health Care coordinated the compensation application, mapped the distribution possibilities and initiated an experience program. At the end of 2012, Titus Health Care transferred all projects concerning Esmya to the Benelux organization of Gedeon Richter.
"Gedeon Richter has selected Titus Health Care as a partner in the preparation for the introduction of Esmya in the Netherlands. Their network of medical specialists in the gynaecological field, enthusiasm combined with perseverance ensured that the project went well and prosperous".
Isabelle De Walsche, Managing Director Gedeon Richter Benelux